Why is Immunohistochemical Staining Useful?

Immunohistochemical staining allows a pathologist to view both healthy and abnormal cells through the use of protein markers. This helps with tumor classification and diagnosis. The presence of Paget’s disease cells can be confirmed through the use of histochemical stains. Typically, extramammary Paget’s disease (EMPD) cells stain for low molecular weight cytokeratins (such as CK-7 or CK-20), GATA3, GCDFP-15, and periodic acid-Schiff (PAS).

CK-7 (Cytokeratin 7) stain is the most common for determining EMPD. It is also used for testing for other cancers including: lung, breast, thyroid, endometrium, cervix, ovary, salivary gland and upper GI tract, urothelial carcinoma, and papillary renal cell carcinoma. Under a microscope, a positive CK-7 test for EMPD will typically demonstrate large, pale staining to clear intraepidermal neoplastic cells containing abundant mucin, arranged singly or occasionally in nests or gland-like formations. Associated changes include squamous hyperplasia, fibroepithelioma-like hyperplasia and papillomatous hyperplasia.

CK-20 (Cytokeratin 20) stain is sometimes used to determine secondary cancers which may be associated with EMPD. The combination of CK-7 and CK-20 can help distinguish primary EMPD from cancer that may have spread. Gross cystic disease fluid protein 15 (GCDFP-15) or GATA3 are also sometimes used.

It can be challenging to distinguish between secondary and primary EMPD, especially if the primary EMPD invades the epidermis or if other cancers are not apparent. Immunohistochemical staining with CK-7, CK-20, and GCDFP-15 may be useful to distinguish them. Primary EMPD is commonly positive for CK-7 and GCDFP-15 but negative for CK-20. Secondary EMPD is usually positive for CK-20 while primary EMPD is negative for CK-20 but this is not always the case. The use of immunohistochemical staining is also important to rule out other cancers.

Some studies also indicate that both in situ EMPD and invasive EMPD may express PD-L1, with the invasive EMPD showing a greater expression.

Since EMPD cases vary widely, it is important to work with your physician to determine the best testing and treatment plan for your situation. This information is not intended as a substitute for professional medical care.

The content presented on this website, encompassing both textual material and visual media, serves educational and informational purposes aimed at aiding individuals affected by extramammary Paget’s disease (EMPD) and their families in comprehending the complexities associated with EMPD. It is imperative to note that the website is not designed to serve as a replacement for professional medical advice, diagnosis, or treatment. Furthermore, the website does not advocate for or endorse any specific treatments, tests, physicians, procedures, or products. Should you suspect that you are experiencing symptoms of EMPD, we strongly advise you to seek guidance from your healthcare provider.